TherapeuticsMD, Inc. (TXMD)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2026-03-30) · 99.1 | 8-K (2025-11-13) · 99.1 | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-03-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-10) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-03-29) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Comprehensive (unaudited) | — |
|
| Condensed Consolidated Statements of Comprehensive Income | — |
|
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive (unaudited) (P) | — |
|
| Condensed Consolidated Statements of Operations (unaudited) (P) | — |
|
| Consolidated Statements of Stockholders Equity | ||
| Condensed Consolidated Statements of Stockholders Equity (deficit) (unaudited) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders (deficit) Equity | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Business Concentrations | ||
| Business, Basis of Presentation, New Accounting Standards and Summary of Significant Accounting Policies | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | — |
|
| Discontinued Operations | ||
| Earnings (loss) Per Common Share | — |
|
| Fixed Assets | ||
| Income (loss) Per Common Share | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Interest and Financing Costs | — |
|
| Licensed Rights and Other Intangible Assets | ||
| Loss Per Common Share | ||
| Pay Vs Performance Disclosure | ||
| Prepaid and Other Current Assets | ||
| Related Parties | ||
| Revenue | ||
| Segment Reporting | ||
| Stockholders Equity | ||
| Stockholders Equity (deficit) | ||
| Subsequent Events | ||